Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Net Cash Flow (2016 - 2020)

Glucotrack's Net Cash Flow history spans 7 years, with the latest figure at -$851000.0 for Q4 2020.

  • For the quarter ending Q4 2020, Net Cash Flow fell 6.71% year-over-year to -$851000.0, compared with a TTM value of $9.5 million through Dec 2020, up 3325.72%, and an annual FY2025 reading of $1.7 million, up 48.56% over the prior year.
  • Net Cash Flow for Q4 2020 was -$851000.0 at Glucotrack, down from -$796000.0 in the prior quarter.
  • The five-year high for Net Cash Flow was $12.0 million in Q1 2020, with the low at -$1.1 million in Q3 2019.
  • Average Net Cash Flow over 5 years is $511238.0, with a median of -$482948.0 recorded in 2016.
  • Year-over-year, Net Cash Flow tumbled 217.35% in 2019 and then surged 16939.67% in 2020.
  • Tracing GCTK's Net Cash Flow over 5 years: stood at -$730109.0 in 2016, then skyrocketed by 43.66% to -$411343.0 in 2017, then plummeted by 100.68% to -$825485.0 in 2018, then increased by 3.39% to -$797512.0 in 2019, then decreased by 6.71% to -$851000.0 in 2020.
  • Per Business Quant, the three most recent readings for GCTK's Net Cash Flow are -$851000.0 (Q4 2020), -$796000.0 (Q3 2020), and -$903000.0 (Q2 2020).